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Abstract
Background: Anti-N-methyl-D-aspartate receptor encephalitis is a rare autoimmune disease characterized by severe
neurological and psychiatric symptoms and a difficult diagnosis.
The disease is often secondary to a neoplastic lesion, seldom diagnosed years later. Psychiatric symptoms are
prevalent in adults; neurologic symptoms are more evident in children, who typically present primarily with
neurological symptoms. To the best of our knowledge, the association with juvenile idiopathic arthritis has not
been described.
Case presentation: We report the cases of two caucasian girls with an atypical presentation.
The first patient was an 8-year-old girl with normal psychomotor development. Over a 4-month period she
developed behavioral problems, speech impairment, and deterioration in academic skills. Within 8 months from
the onset of symptoms, choreic movements gradually appeared. Hematological, neuroradiological, and
neurophysiological examinations were negative; however, her symptoms worsened and treatment with
prednisone was started. Although her choreic movements improved within 1 month, her neuropsychological and
behavioral symptoms continued. Anti-N-methyl-D-aspartate receptor antibodies in cerebrospinal fluid and in
blood were detected. Therapy with intravenously administered immunoglobulins was administered, without
improvement of symptoms. After 2 months of steroid treatment, she suddenly started to pronounce some
words with a progressive improvement in language and behavior.
The second patient was a 14-year-old girl with classic anti-N-methyl-D-aspartate receptor encephalitis, treated successfully
with intravenously administered immunoglobulins and methylprednisolone, followed by orally administered prednisone,
who developed chronic arthritis of the hip. The arthritis was confirmed by magnetic resonance imaging and associated to
antinuclear antigen antibody positivity.
One year after the encephalitis presentation, an ovarian cystic mass was identified as a teratoma. The surgical resection of
the mass was followed by the resolution of the psychotic spectrum and arthritis.
Conclusions: Anti-N-methyl-D-aspartate receptor encephalitis in pediatric patients can present initially with
neuropsychological and behavioral symptoms.
In the literature, the association of anti-N-methyl-D-aspartate receptor encephalitis with juvenile idiopathic arthritis is not
yet described: to the best of our knowledge, this is the first case reported. The link to a neoplastic lesion can explain the
favorable course of encephalitis and arthritis, after the surgical resection of the mass. Early diagnosis and treatment can
improve the patient’s outcome.
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Background
Anti-N-methyl-D-aspartate receptor (NMDAR) encepha-
litis is a recently described disease characterized by five
stages of development (prodromal phase, psychotic phase,
unresponsive phase, hyperkinetic phase, and gradual re-
covery phase), with a prevalence of psychiatric symptoms
in adult patients and neurological symptoms in pediatric
patients.
The presenting features are: behavioral changes,
psychosis, seizures, oro-lingual-facial dyskinesia, extreme
irritability, and insomnia. The symptoms are persistent,
and the course is usually progressive over 4 to 8 weeks’
duration [1–3].
The diagnosis is based on detection of anti-NMDAR
antibodies, since neuroimaging and electroencephalog-
raphy (EEG) are nonspecific.
An atypical presentation of the disease in children can
result in a delay in diagnosis and appropriate treatment.
Intravenous pulse methylprednisolone and immunoglob-
ulins are the first-line treatment. Some children require
second-line immunotherapy. In the literature rituximab
is reported as useful, and the response to cyclophospha-
mide pulse therapy is satisfactory. Although the response
to corticosteroids and/or immunoglobulins can be quite
variable, early diagnosis of the illness can be crucial in
improving the patient’s outcome. A tumor screen is
mandatory in all children to detect neoplastic lesions
often found to be etiologically linked to the encephalitis.
Ovarian teratoma is often associated [4]. The outcome
depends on the histological type, the spectrum of associ-




The first patient was a healthy 8-year-old caucasian girl.
Her parents were divorced and she lived with her mother,
but she saw her father every week. At 7 years of age, she
had developed cystitis with urinary incontinence. The
condition resolved; however, her behavior changed when
she started school. She became agitated and hyperactive
and experienced frequent episodes of tachycardia. She
would wake up in the middle of the night and jump on
her bed. In addition, she became very anxious and at-
tached to her mother, and she continuously asked her
mother if she loved her. Moreover, she exhibited frequent
bouts of laughing and crying during the day for no
apparent reasons. She spoke “like a little girl” (baby talk)
and her academic skills progressively worsened. A
pediatric neurologist diagnosed her with anxiety. An EEG
recording during wakefulness was normal, while neuro-
psychological testing showed a deficit in executive func-
tioning. After a few months she developed symptoms of
dysarthria and eventually stopped speaking altogether 2
months later. She subsequently developed a low-grade
fever and a complex partial seizure. Subsequently hospital-
ized under our observation she presented as impatient
and hyperactive. She was very communicative in non-
verbal ways and excessively friendly, but anxious at the
same time. She did not sleep, but when she did fall asleep,
she would wake up frequently. Although she did not
speak, the communicative intent was clear. Her gestures
were used appropriately, but her only verbal utterance was
to say in an explosive way “mama” and “no.” Her verbal
comprehension was preserved even for the most complex
requests. Choreiform dyskinesia was present in her facial
muscles and limbs.
Diagnostic testing including magnetic resonance im-
aging (MRI) and computed tomography (CT) scan of
her brain, blood levels of copper, throat swab, blood
and urine levels of amino acids, electrocardiogram
(EKG), echocardiography, and repeated EEG during
sleep and wakefulness were all normal. Antistreptolysin
O titer, complete blood count, liver and renal function
tests, and inflammation and infection markers were in
the normal range.
Symptomatic treatment with haloperidol (0.1 mg/kg)
was started and her neurological symptoms quickly im-
proved. After 2 days, her choreic movements were re-
duced as shown by Sydenham’s Chorea Rating Scale
(USCRS), in which total score decreased from 4 to 2.
Approximately 10 days after beginning treatment, her
choreic movements decreased further. Language, how-
ever, was still limited to a few words. Sleep disturbances
were still present even when her hyperactivity and disin-
hibition were reduced. Treatment with prednisone at a
dose of 2 mg/kg per day was started. Her choreic move-
ments disappeared completely and her parents reported
that she was able to speak a few sentences when she
sang. Treatment with haloperidol was then stopped and
corticosteroid treatment continued. After approximately
a month of therapy with prednisone the clinical picture
was still characterized by a significant impairment in
speech and the persistence of behavioral symptoms.
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A lumbar puncture was then performed because we
suspected a diagnosis of autoimmune encephalitis. A
cerebrospinal fluid (CSF) examination showed oligoclo-
nal bands with a type 3 pattern and the presence of anti-
NMDAR antibodies. CSF glucose and proteins levels
were within normal limits: 44 mg/dl (normal values 32
to 82 mg/dl) and 16.60 mg/dl (normal values 15 to 45
mg/dl), respectively. No cells were found. Anti-NMDAR
antibodies were also present in a blood sample. Ultra-
sound excluded the presence of ovarian teratoma and a
chest X-ray was normal. Therapy with intravenously ad-
ministered immunoglobulin (IVIG) at the dose of 1 g/kg
was given and corticosteroid treatment continued. After
2 months of the IVIG infusion, she started to pronounce
words and within a few days, language was completely
restored. Four weeks later, steroid therapy was reduced
to 12.5 mg/day; however, she again began to have diffi-
culties in speech production and the therapy was re-
sumed. Neurological problems eventually disappeared.
Nine months later, steroid therapy was reduced and fi-
nally discontinued. One year later, speech was restored
and she was completely asymptomatic and no further
relapses occurred.
Case 2
A 14-year-old caucasian girl presented to our unit with
an acute onset of neuropsychiatric disorders, character-
ized by a severely agitated state, headache, speech and
swallowing difficulties, generalized seizures, which in a
few days developed into a severely agitated catatonic
state with opisthotonic posturing, tonic posturing of
limbs, insomnia, and dyskinesia. She further manifested
loss of sensitivity in the distal portion of her left leg.
She also developed left hip arthritis, with pain and func-
tional impairment of articular movements. The arthritis
was confirmed by MRI, showing joint effusion and syn-
ovial membrane hypertrophy. Brain MRI was free from
abnormalities; CSF analysis was in the normal range for
leukocytes, proteins, and anti-NMDAR antibodies; equally
negative was CSF detection of herpes simplex virus type 1
(HSV-1) by polymerase chain reaction (PCR). EEG
showed focal slow-waves in the front central area.
Serum antinuclear antigen antibodies (ANA) were posi-
tive, with a titer of 1:160; serum anti-NMDAR antibodies
were also positive, while anti-cardiolipin antibodies and
lupus anticoagulant were negative. Human leukocyte anti-
gen (HLA)-B27 allele was absent. Alpha-fetoprotein, beta-
human chorionic gonadotropin (beta-hCG), CA125, and
CA19.9 were evaluated periodically during the follow-up
and always showed concentrations in the physiological
range.
An abdominal and pelvic scan, and chest, abdomen
and pelvis CT were evaluated for occult malignancy.
However, initially they did not reveal any neoplastic lesion.
She started a 3-day course of high-dose pulse intraven-
ous methylprednisolone (30 mg/kg per day), followed by
orally administered prednisone (2 mg/kg per day weaned
over 3 months) and IVIGs 400 mg/kg per day for 5 days.
Further, she received haloperidol for her movement dis-
orders. Her psychiatric and neurological symptoms re-
solved; however, the loss of feeling in her leg was lasting.
She received non-steroidal anti-inflammatory drugs
for the arthritis persistence, with a slow reduction of
pain, functional limitation, and swelling.
Furthermore, a relapse of psychiatric symptoms oc-
curred with agitated catatonic state and dyskinesia.
She was treated with a second course of steroids (or-
ally administered prednisone 2 mg/kg per day) and IVIG
(400 mg/kg per day for 5 days). Ultrasound, CT, and
MRI screening for occult malignancy were repeated and
revealed an ovarian teratoma. The teratoma was surgi-
cally removed, with a resolution of her psychiatric and
neurological manifestations.
A second flare of arthritis occurred, and resolved after 1
month of treatment with non-steroidal anti-inflammatory
drugs.
Discussion
Anti-NMDAR encephalitis is a disorder caused by anti-
bodies to the NR1 subunit of the NMDAR and has been
recognized as the most frequent autoimmune encephalitis
in children after acute demyelinating encephalomyelitis
[5]. The encephalitis is associated with the production of
auto-antibodies directed to NMDAR, a protein involved
in memory function and synaptic plasticity. The patients’
antibodies have in fact pathogenic effects on the NMDAR.
Anti-NMDAR encephalitis is characterized by the pres-
ence of neurological and psychiatric symptoms. Isolated
psychiatric symptoms are rare at the onset of the disease
in children. They are more frequent in adults and more
typical during relapses [1]. Patients develop neurological
and/or psychiatric symptoms 2 to 4 weeks following the
prodromal phase of the illness (usually upper respiratory
tract symptoms, fever, nausea, headache, vomiting, or
diarrhea) [2, 6]. The psychiatric symptoms in adults and
in adolescents are usually characterized by anxiety, delu-
sional thinking, mania, paranoia, and visual and auditory
hallucinations. Sleep disorders, especially insomnia, are
also common. In contrast, children present more fre-
quently with irritability, bouts of inappropriate laughing
or crying, hyperactivity, temper tantrums, and violent be-
haviors, in addition to insomnia and anxiety. Deterioration
in speech is frequently reported in both in pediatric and
adult ages as an initial symptom [1]. In the 12 years and
under age group, the initial symptoms are usually neuro-
logical, consisting of dystonia, dyskinesia, and/or seizures
(usually partial seizures) [2].
Maggio et al. Journal of Medical Case Reports  (2017) 11:225 Page 3 of 5
In the 32 patients described by Florance et al. [1], 84%
and 77% showed movement disorders and seizures re-
spectively, and 59% showed behavioral/personality disor-
ders. In another series, 67% of patients younger than 12
years of age initially showed neurologic symptoms and
33% psychiatric symptoms [7].
The EEG either at the onset or during the disease course
is abnormal in 90 to 100% of cases [8]. The sensitivity of
MRI is lower, being positive in 30 to 55% of cases [6].
In their pediatric series of 20 cases, Armangue et al. [2]
grouped the symptoms of anti-NMDAR encephalitis into
nine categories: behavioral dysfunctions, sleep dysfunction,
memory deficit, speech dysfunction, movement disorder,
seizures, loss of consciousness, autonomic dysfunction,
and central hypoventilation. They showed that within the
first month of the disease each patient developed a median
number of symptoms equal to 5.5 (range 4 to 8). Psy-
chiatric dysfunction, impaired speech, and abnormal move-
ments (usually orofacial dyskinesia and choreoathetosis)
developed at varying timeframes over the course of the
illness.
Patient 1 showed all the neurological, neuropsycho-
logical, and psychiatric symptoms typical of NMDAR
encephalitis, although the timing of their appearance
was atypical and neuroradiological and electroencepha-
lographic examinations were negative. In fact, she was
referred for our attention 9 months after the onset of
psychiatric symptoms, and child abuse had been hypo-
thesized as a possible cause for her clinical presentation.
The sole initial neurological symptom in case 1 was a
complex partial seizure, which occurred 8 months after
the onset of disease. The dystonic/dyskinetic movement
disorder became fully expressed after another month.
EEG and MRI remained negative, even when neuro-
logical signs and symptoms were present.
The disease can be linked to neoplastic lesions, more
frequently gonadic teratoma. These cases are considered
a paraneoplastic syndrome, and surgery of the teratoma
can resolve neurological symptoms. Surgery probably
removes antigenic stimulus of autoimmunity. Especially
in teratoma several different tissues are detected, with
possible autoimmune cross-mimicry [9]. However, in
many cases the tumors are not detectable and the pa-
tients have a clinical course linked to the pharmaco-
logical treatment.
The disease has a well-delineated set of clinical fea-
tures, with neuropsychiatric expression. In the case 2,
behavior changes were associated with agitation, head-
aches, memory deficit, and speech problems. She also
showed bizarre movements of hands and legs and
seizures.
As an autoimmune disease, an association with other
autoimmune and/or rheumatologic diseases could be
observed.
In the literature, only one case of anti-NMDAR en-
cephalitis in an adult patient, with long-term seroposi-
tive rheumatoid arthritis (RA), was described. This case
showed an atypical presentation which developed while
she was under biologic therapy [10].
The association with juvenile idiopathic arthritis (JIA)
has not, however, been described yet: to the best of our
knowledge, this is the first case reported in the literature.
Furthermore, the link to a neoplastic lesion can explain
the favorable course after the surgical resection of the
mass and the favorable course of arthritis as well.
Conclusions
For the acute psychosis, many patients are first followed
by psychiatrists: pediatricians and psychiatrists must
consider anti-NMDAR encephalitis as a possible cause
of acute psychosis in children and adolescents without a
history of psychiatric events [5, 8].
In these patients, an accurate follow-up must exclude
an occult neoplasm; the diagnostic pattern must include
imaging with neoplastic biomarkers (such as CA125,
CA19.9) for the identification of the most common neo-
plasm: ovarian teratoma [11]. However, a normal range
of CA19.9 does not exclude a teratoma, as documented
in our patient.
The association of other autoimmune diseases could
help physicians with the diagnostic path.
Finally, although it is known that symptoms respond
after a long period of time to immunomodulatory therapy
with corticosteroids and immunoglobulins, it remains
questionable if a timely treatment start could shorten the
neuropsychological and neurological recovery.
In conclusion, in the absence of neurological symp-
toms and a negative EEG, anti-NMDAR encephalitis
must be kept in mind as a differential diagnosis in a
young child presenting mainly with psychiatric symp-
toms. Initiation of appropriate treatment in a timely
manner may result in a most favorable outcome.
Furthermore, the possible coexistence of other auto-
immune diseases in these patients stresses the usefulness
of a long-term follow-up from the pediatric age to young
adulthood for the precocious recognition of other asso-
ciated autoimmune diseases.
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